Close ✕
Health U.S.
Photo: PhillyVoice

Newborn Vitamin K Refusals Rise as Bleeding Risks Increase

Two studies of U.S. newborns found that vitamin K shot refusals have risen since 2017, alongside increases in bleeding associated with vitamin K deficiency. The shot is recommended soon after birth to help prevent potentially severe bleeding; vitamin K helps blood clot, and newborns have low levels of it.

In the JAMA study, researchers analyzed more than 5.2 million health records. The share of newborns without a shot more than doubled, from 3.1% in 2017 to 6.8% in 2025. The rate increased from 5.6% to 6.8% between 2024 and 2025.

That study found infants who did not receive the shot had a 47% higher risk of any recorded bleeding event in their first six months than infants who did. Their risk of brain bleeding more than doubled, as did their chance of dying before leaving the hospital after birth.

A separate JAMA Pediatrics study examined records for more than 11 million infants born from 2017 to 2025. It found the number who missed the shot doubled, while vitamin K deficiency bleeding rose 347%, reaching 107.4 cases per 100,000 infants.

Doctors warn that late bleeding can occur without warning and may cause brain injury or death. About half of infants with late vitamin K deficiency bleeding have brain bleeds, the CDC says. The American Academy of Pediatrics has recommended the shot since the 1960s. After an investigation published in May documented bleeding and deaths following refusals, lawmakers urged the CDC to track shot uptake and related deaths and publish the information.

Reported by ABC7 Los Angeles, PhillyVoice.

Related stories

Top stories now

About